AEON Biopharma holders elect directors, ratify KPMG
AEON Biopharma, Inc. reported results from its Annual Meeting of Stockholders held on June 17, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
AEON Biopharma, Inc. reported results from its Annual Meeting of Stockholders held on June 17, 2026. Stockholders elected Marc Forth and Seongsoo Park as Class III directors to terms ending at the 2029 annual meeting, with 13,297,322 and 13,117,299 votes "for," respectively.
Stockholders also ratified the appointment of KPMG LLP as AEON Biopharma’s independent registered public accounting firm for the fiscal year ended December 31, 2026, with 21,502,418 votes "for," 18,217 "against" and 1,498 "abstain."
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Marc Forth: 13,297,322 votes
Votes for Seongsoo Park: 13,117,299 votes
Broker non-votes on director elections: 8,197,073 votes
+3 more
6 metrics
Votes for Marc Forth
13,297,322 votes
Election as Class III director, term expiring 2029
Votes for Seongsoo Park
13,117,299 votes
Election as Class III director, term expiring 2029
Broker non-votes on director elections
8,197,073 votes
For each Class III director election
Votes for KPMG ratification
21,502,418 votes
Ratification of KPMG LLP as auditor for fiscal year ended Dec. 31, 2026
Votes against KPMG ratification
18,217 votes
Ratification of KPMG LLP for 2026 fiscal year
Abstentions on KPMG ratification
1,498 votes
Ratification of KPMG LLP for 2026 fiscal year
Key Terms
Annual Meeting of Stockholders, Class III directors, broker non-vote, independent registered public accounting firm, +1 more
5 terms
Annual Meeting of Stockholders financial
"held its Annual Meeting of Stockholders on June 17, 2026"
Class III directors financial
"elected each of Marc Forth and Seongsoo Park as Class III directors"
Class III directors are members of a company’s board assigned to one of several staggered term groups, so only that class faces election in a particular year while other classes stay in place. For investors this affects corporate control and takeover risk because staggered elections make it slower and harder for an outside group to replace a majority of directors quickly—think of it as a rotating schedule for board seats that provides continuity but can also entrench existing leadership.
broker non-vote financial
"For, Withheld, Broker Non-Vote"
A broker non-vote happens when a brokerage firm holds shares in street name for a client but does not cast a ballot on a particular shareholder item because the broker lacks discretionary authority to vote that matter. Think of it like a person who owns a ticket but the ticket-holder refuses to vote on some issues; the share counts for ownership but not for that vote, which can affect whether proposals reach the required number of votes or a quorum.
independent registered public accounting firm financial
"KPMG LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were AEON (AEON) director nominees elected at the June 17, 2026 meeting?
Yes. Marc Forth and Seongsoo Park were elected as Class III directors. Their terms run until the annual meeting of stockholders to be held in 2029 and until their respective successors are duly elected and qualified.
How many votes did AEON director nominee Marc Forth receive?
Marc Forth received 13,297,322 votes "for" and 27,738 votes "withheld," with 8,197,073 broker non-votes. These results certified his election as a Class III director with a term expiring at the 2029 annual meeting.
How many votes did AEON director nominee Seongsoo Park receive?
Seongsoo Park received 13,117,299 votes "for" and 207,761 votes "withheld," along with 8,197,073 broker non-votes. This voting outcome confirmed his election as a Class III director through the 2029 annual meeting of stockholders.
Did AEON (AEON) stockholders ratify KPMG LLP as auditor for 2026?
Yes. Stockholders ratified KPMG LLP as AEON Biopharma’s independent registered public accounting firm for the fiscal year ended December 31, 2026, with 21,502,418 votes "for," 18,217 "against," 1,498 "abstain," and no broker non-votes reported.
What is a broker non-vote in AEON’s 2026 annual meeting results?
A broker non-vote appears where brokers did not have authority to vote uninstructed shares on a proposal. AEON reported 8,197,073 broker non-votes for each director election proposal, while no broker non-votes were recorded for the auditor ratification.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates